Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference

   Verenium To Sponsor The Renewable Fuels Association 18th Annual National
                              Ethanol Conference

PR Newswire

SAN DIEGO, Feb. 4, 2013

SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a
leading industrial biotechnology company focused on the development and
commercialization of high-performance enzymes, today announced that the
Company is a sponsor of the Renewable Fuels Association's (RFA) 18^th Annual
National Ethanol Conference. The conference is taking place February 5 – 7,
2013 at the Wynn Las Vegas in Las Vegas, Nevada.


The RFA's National Ethanol Conference is recognized as one of the premier
forums for the ethanol industry to come together and work to address the
current market situation and issues facing the industry. Verenium is pleased
to support such an important event and to be part of the discussion on how
products like Verenium's Fuelzyme^® alpha-amylase enzyme, can help ethanol
producers recognize multiple sources of savings such as reduced chemical usage
and dose reduction, and improve plant profitability in tough market

To learn more about Fuelzyme^® alpha-amylase and Verenium's other grain
processing enzyme solutions, look for product information on the sponsor table
at the upcoming 18th Annual RFA National Ethanol Conference or contact
Verenium Customer Relations at and 1.800.523.2990.

For more information on the RFA's National Ethanol Conference visit 

About Verenium
Verenium, an industrial biotechnology company, is a global leader in
developing high-performance enzymes. Verenium's tailored enzymes are
environmentally friendly, making products and processes greener and more
cost-effective for industries, including the global food and fuel markets.

Forward Looking Statements for Verenium
Statements in this press release that are not strictly historical are
"forward-looking" and involve a high degree of risk and uncertainty. These
include, but are not limited to, statements related to Verenium's ability to
commercialize its products, enhance its manufacturing capabilities, capture
near-term and longer-term growth and prospects, and reach profitability. Such
statements are only predictions, and actual events or results may differ
materially from those projected in such forward-looking statements. Factors
that could cause or contribute to the differences include, but are not limited
to, risks associated with Verenium's strategic focus, technologies, products
and product candidates and product pipeline (including Verenium's ability to
identify, develop and commercialize new products and product candidates,
either independently or with collaborators or partners, and market demand for
those products and product candidates), dependence on patents and proprietary
rights, protection and enforcement of its patents and proprietary rights, the
commercial prospects of the industries in which Verenium operates and sells
products, Verenium's dependence on manufacturing and/or license agreements,
its ability to achieve milestones under existing and future collaboration
agreements, the ability of Verenium and its partners to commercialize its
technologies and products (including by obtaining any required regulatory
approvals) using Verenium's technologies, the timing for launching any
commercial products and projects, the ability of Verenium and its
collaborators to market and sell any products that it or they commercialize,
the development or availability of competitive products or technologies, the
future ability of Verenium to enter into and/or maintain collaboration and
joint venture or partnership agreements and licenses on a timely basis or at
all, and risks and other uncertainties more fully described in Verenium's
filings with the Securities and Exchange Commission, including, but not
limited to, Verenium's annual report on Form 10-K for the year ended December
31, 2011 and any updates contained in its subsequently filed quarterly reports
on Form 10-Q . These forward-looking statements speak only as of the date
hereof, and Verenium expressly disclaims any intent or obligation to update
these forward-looking statements.

Contacts for Verenium:

Sarah Carmody

Sr. Corporate Communications Manager


SOURCE Verenium Corporation

Press spacebar to pause and continue. Press esc to stop.